temozolomide has been researched along with Neoplastic Processes in 2 studies
Neoplastic Processes: The pathological mechanisms and forms taken by tissue during degeneration into a neoplasm and its subsequent activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glioblastoma patients commonly develop resistance to temozolomide chemotherapy." | 8.31 | Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion. ( Bindila, L; Geiß, C; Kim, E; Lieberwirth, I; Régnier-Vigouroux, A; Sousa, N, 2023) |
| "Glioblastoma patients commonly develop resistance to temozolomide chemotherapy." | 4.31 | Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion. ( Bindila, L; Geiß, C; Kim, E; Lieberwirth, I; Régnier-Vigouroux, A; Sousa, N, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sousa, N | 1 |
| Geiß, C | 1 |
| Bindila, L | 1 |
| Lieberwirth, I | 1 |
| Kim, E | 1 |
| Régnier-Vigouroux, A | 1 |
| Dumitru, CA | 1 |
| Schröder, H | 1 |
| Schäfer, FTA | 1 |
| Aust, JF | 1 |
| Kreße, N | 1 |
| Siebert, CLR | 1 |
| Stein, KP | 1 |
| Haghikia, A | 1 |
| Wilkens, L | 1 |
| Mawrin, C | 1 |
| Sandalcioglu, IE | 1 |
2 other studies available for temozolomide and Neoplastic Processes
| Article | Year |
|---|---|
Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion.
Topics: Antineoplastic Agents; Cell Death; Glioblastoma; Humans; Neoplasm Recurrence, Local; Neoplastic Proc | 2023 |
Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma.
Topics: Brain Neoplasms; Glioblastoma; Humans; Membrane Proteins; Neoplastic Processes; Receptors, Progester | 2023 |